Retrospective evaluation of palifermin use in nonhematopoietic stem cell transplant pediatric patients Journal Article


Authors: Liu, D.; Seyboth, B.; Mathew, S.; Gilheeney, S. W.; Chou, A. J.; Drill, E.; Kobos, R.
Article Title: Retrospective evaluation of palifermin use in nonhematopoietic stem cell transplant pediatric patients
Abstract: Background: Palifermin has been proven to decrease the frequency of severe oral mucositis in adult patients with sarcoma and metastatic colorectal cancer receiving chemotherapy. The impact of palifermin on the incidence of mucositis in nonhematopoietic stem cell transplantation (HSCT) pediatric population receiving chemotherapy has never been reported to date. Patients and Methods: This is a retrospective analysis of pediatric patients who received palifermin as secondary prophylaxis to prevent chemotherapy-induced mucositis at Memorial Sloan Kettering Cancer Center from January 1, 2008 to 2014. Data from electronic medical records on days to mucositis resolution, use of opioids, use of total parenteral nutrition, duration of hospitalization, and antibiotics are collected and presented here. Results: A total of 18 patients received palifermin for secondary prophylaxis after developing mucositis from the prior chemotherapy cycle. Mucositis did not reoccur in the subsequent cycle for 13 of the 18 patients. The majority of patients who received palifermin prophylaxis had decreased opioids and antibiotics use and decreased duration of hospitalization. Six of the 7 patients previously requiring total parenteral nutrition due to mucositis had decreased supplemental nutritional needs following the use of palifermin. Conclusion: Palifermin may provide benefit as secondary prophylaxis in pediatric patients to prevent chemotherapy-induced mucositis. © 2017 Wolters Kluwer Health, Inc. All rights reserved.
Keywords: palifermin; chemotherapy-induced mucositis; secondary prophylaxis
Journal Title: Journal of Pediatric Hematology/Oncology
Volume: 39
Issue: 4
ISSN: 1077-4114
Publisher: Lippincott Williams & Wilkins  
Date Published: 2017-05-01
Start Page: e177
End Page: e183
Language: English
DOI: 10.1097/mph.0000000000000791
PROVIDER: scopus
PUBMED: 28234746
DOI/URL:
Notes: Article -- Export Date: 1 June 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Ja-Ho Chou
    58 Chou
  2. Rachel Kobos
    75 Kobos
  3. Sherry Mathew
    19 Mathew
  4. Brian Michael Seyboth
    11 Seyboth
  5. Esther Naomi Drill
    93 Drill
  6. Dazhi   Liu
    45 Liu